tiprankstipranks
Trending News
More News >
HeartCore Enterprises, Inc. (HTCR)
NASDAQ:HTCR
US Market

HeartCore Enterprises, Inc. (HTCR) AI Stock Analysis

Compare
107 Followers

Top Page

HTCR

HeartCore Enterprises, Inc.

(NASDAQ:HTCR)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
$0.28
▼(-9.35% Downside)
The score is primarily held back by deteriorating financial performance (steep revenue decline, worsening margins and losses, and negative operating/free cash flow). Technical indicators reinforce the weakness with a clear downtrend and negative momentum. Valuation is hard to assess due to losses (negative P/E) despite a very high dividend yield, while the subsidiary sale is a modest positive offset but not enough to overcome the fundamental and technical pressures.
Positive Factors
Lower Leverage
Material reduction in leverage meaningfully improves financial flexibility and reduces interest cost sensitivity. Over 2–6 months this gives management room to fund restructuring, cover shortfalls, or pursue targeted investments without relying on high-cost debt or immediate asset sales.
Strategic Divestiture
Divesting the Japan unit and reallocating capital toward Go IPO consulting is a structural pivot that narrows focus to higher-margin consulting services. Proceeds provide cash to shore up operations or return to shareholders, reducing reliance on underperforming software assets long-term.
Diversified Revenue Streams
Multiple income sources—device sales, subscription services, partnerships and digital advertising—create structural resilience. Recurring app subscriptions and partnerships can stabilize cash flow versus pure product sales, supporting steadier revenue composition over coming quarters.
Negative Factors
Steep Revenue Decline
A roughly 50% TTM revenue decline erodes scale economies and brand momentum, reducing ability to cover fixed costs and invest in product development. Persisting revenue contraction over several quarters jeopardizes long-term competitiveness and the sustainability of core offerings.
Margin & Profitability Deterioration
Sharp gross margin compression and deep negative net margins indicate structural issues with pricing, product mix, or cost control. Persistent poor profitability limits reinvestment, raises funding needs, and undermines the viability of growth initiatives without substantive margin recovery.
Negative Cash Flow
Sustained negative operating and free cash flow constrains capital allocation and forces reliance on asset sales, equity or debt. Declining FCF growth reduces runway for R&D, marketing, and scaling, making operational turns and strategic investments difficult without external financing.

HeartCore Enterprises, Inc. (HTCR) vs. SPDR S&P 500 ETF (SPY)

HeartCore Enterprises, Inc. Business Overview & Revenue Model

Company DescriptionHeartCore Enterprises, Inc., a software development company, provides Software as a Service solutions to enterprise customers in Japan and internationally. Its customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. The company also provides data analytics services that allow enterprise businesses to create web experiences for their clients. In addition, it operates a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises. The company was founded in 2009 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyHeartCore Enterprises, Inc. generates revenue through multiple key streams. Primarily, the company earns income from the sale of its health monitoring devices and related accessories, which are marketed directly to consumers via its e-commerce platform and through retail partnerships. Additionally, HTCR offers subscription-based services for its mobile applications, providing users with premium features and personalized health insights. The company also benefits from collaborations with health-focused organizations and research institutions, which contribute to product development and innovation, enhancing its market reach and brand credibility. Advertising and affiliate marketing on its digital platforms further augment its revenue, creating a multifaceted approach to generating income.

HeartCore Enterprises, Inc. Financial Statement Overview

Summary
Weak fundamentals overall: revenue is down sharply (TTM growth -50.16%), margins deteriorated materially (gross margin 58.63% to 36.29%), and losses deepened (TTM net margin -73.58%). Balance sheet leverage improved (debt-to-equity 0.81 to 0.04), but profitability remains very weak (ROE -262.95%) and cash flow is negative with declining free cash flow growth (-28.51%).
Income Statement
35
Negative
HeartCore Enterprises, Inc. has experienced a significant decline in revenue, with a TTM revenue growth rate of -50.16%. The gross profit margin has decreased from 58.63% in 2024 to 36.29% in the TTM period, indicating reduced profitability. The net profit margin has also worsened, moving from -4.87% in 2024 to -73.58% in the TTM period. These metrics suggest challenges in maintaining revenue and controlling costs, impacting overall profitability.
Balance Sheet
40
Negative
The company's debt-to-equity ratio has improved significantly from 0.81 in 2024 to 0.04 in the TTM period, indicating reduced leverage. However, the return on equity remains negative at -262.95%, reflecting ongoing losses. The equity ratio is stable at 38.92%, suggesting a reasonable level of equity financing relative to total assets. Despite improvements in leverage, profitability remains a concern.
Cash Flow
30
Negative
Operating cash flow and free cash flow are both negative, with a TTM free cash flow growth rate of -28.51%. The operating cash flow to net income ratio is -0.47, indicating cash flow challenges. The free cash flow to net income ratio is slightly above 1, suggesting that free cash flow is closely aligned with net income, albeit negative. Cash flow management remains a critical issue for the company.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue14.77M30.41M21.85M8.82M10.82M9.03M
Gross Profit5.36M17.83M8.07M3.35M5.19M4.02M
EBITDA-14.35M-4.46M-4.16M-6.55M163.53K399.69K
Net Income-10.81M-1.48M-4.19M-6.68M-338.16K150.96K
Balance Sheet
Total Assets13.34M13.97M19.62M12.14M9.12M10.36M
Cash, Cash Equivalents and Short-Term Investments4.35M6.62M1.95M7.18M3.14M3.06M
Total Debt946.72K3.78M4.89M4.55M6.19M8.49M
Total Liabilities9.51M10.50M11.96M7.33M9.68M11.42M
Stockholders Equity5.19M4.65M5.17M4.81M-558.95K-1.41M
Cash Flow
Free Cash Flow-4.26M-4.78M-4.86M-4.87M730.15K718.58K
Operating Cash Flow-4.26M-4.77M-4.33M-4.81M766.30K745.75K
Investing Cash Flow4.81M6.35M-1.78M-12.20K-179.03K-401.15K
Financing Cash Flow1.21M-318.65K136.19K8.92M-257.35K2.06M

HeartCore Enterprises, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.31
Price Trends
50DMA
0.35
Negative
100DMA
0.53
Negative
200DMA
0.52
Negative
Market Momentum
MACD
-0.03
Negative
RSI
28.29
Positive
STOCH
10.80
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HTCR, the sentiment is Negative. The current price of 0.31 is above the 20-day moving average (MA) of 0.29, below the 50-day MA of 0.35, and below the 200-day MA of 0.52, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 28.29 is Positive, neither overbought nor oversold. The STOCH value of 10.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HTCR.

HeartCore Enterprises, Inc. Risk Analysis

HeartCore Enterprises, Inc. disclosed 66 risk factors in its most recent earnings report. HeartCore Enterprises, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
The value of the equity rights we receive from our GO IPO clients could be volatile, lose value, and even become worthless. Q4, 2023
2.
We provide consulting services and ultimately do not control our client's abilities to go public in the United States or secure a listing on American stock exchanges. Q4, 2023
3.
Our GO IPO business assists companies in navigating the initial public offering process in the US markets. We do not provide investment, accounting, or legal advice. If state or federal regulatory agency determined our Company provided legal or investment advice in violation of existing law, there could be a material adverse effect on our business operations and stock value. Q4, 2023

HeartCore Enterprises, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
48
Neutral
$6.92M-0.36-80.59%-27.47%83.06%
43
Neutral
$6.22M-0.46-5.71%41.26%-51.26%-319.52%
40
Underperform
$7.61M-0.04-269.14%-73.83%98.11%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HTCR
HeartCore Enterprises, Inc.
0.24
-1.14
-82.41%
AMST
Amesite
1.94
-1.31
-40.31%
CXAI
CXApp
0.22
-1.34
-86.15%
FUSE
Fusemachines
2.12
-9.66
-82.00%
TGL
Treasure Global, Inc.
4.54
-170.96
-97.41%
WCT
Wellchange Holdings Company Limited
0.13
-2.01
-93.97%

HeartCore Enterprises, Inc. Corporate Events

Delistings and Listing ChangesStock Split
HeartCore Enterprises Granted Nasdaq Listing Extension
Neutral
Nov 10, 2025

On November 10, 2025, HeartCore Enterprises, Inc. announced it received an additional 180-day extension from the Nasdaq Listing Qualifications Department to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The extension, which lasts until May 1, 2026, has no immediate effect on the company’s stock listing status, but failure to comply could lead to delisting. HeartCore is considering actions such as a reverse stock split to regain compliance, though no decisions have been made yet.

The most recent analyst rating on (HTCR) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 21, 2026